Author:
Zhao Yuqiong,Luo Huijuan,Ren Xiaojie,Jia Binghan,Li Jinzhao,Wang Lixin,Li Junping
Abstract
AbstractThis study was designed to explore the expression changes of P2Y1 receptors in the distal colonic myenteric layer of rats. An opioid induced constipation(OIC) rat model was generated by intraperitoneal (i.p) injection of loperamide. At 7 days post-treatment, the model rats were assessed by calculating the fecal water content and the gastrointestinal transit ratio. The immunofluorescence (IF)-based histochemical study was used to observe the distribution of P2Y1 receptors in the distal colonic myenteric plexus. Western blotting (WB) was performed to evaluate the expression changes of P2Y1 proteins in the myenteric layer, and the electrophysiological approaches were carried out to determine the regulatory roles of P2Y1 receptors on distal colonic motor function. IF showed that P2Y1 receptors are co-expressed MOR in the enteric nerve cells of the distal colonic myenteric plexus. Moreover, the WB revealed that the protein levels of P2Y1 were significantly decreased in the distal colonic myenteric layer of OIC rats. In vitro tension experiments exhibited that the P2Y1 receptor antagonist MRS2500 enhanced the spontaneous contraction amplitude, adding EM2 and β-FNA did not have any effect on MRS2500. Therefore, P2Y1 receptor expression could be associated with the occurrence of OIC in this rat model and the regulation of colonic motility by MOR may be related to the release of purine neurotransmitters such as ATP in the colonic nervous system.
Funder
National Natural Science Foundation of China
Natural Science Foundation of Ningxia Hui Autonomous Region
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Rekatsina M, Paladini A, Drewes AM, Ayob F, Viswanath O, Urits I, et al. Efficacy and safety of peripherally acting µ-Opioid receptor antagonist (PAMORAs) for the management of patients with opioid-Induced Constipation: a systematic review. Cureus. 2021;13:e16201.
2. ALMouaalamy N. Opioid-Induced Constipation in Advanced Cancer patients. Cureus. 2021;13:e14386.
3. Neefjes ECW, van der Wijngaart H, van der Vorst MJDL, ten Oever D, van der Vliet HJ, Beeker A, et al. Optimal treatment of opioid induced constipation in daily clinical practice– an observational study. BMC Palliat Care. 2019;18:31.
4. Roeland EJ, Sera CJ, Ma JD. More opioids, more constipation? Evaluation of longitudinal total oral opioid consumption and self-reported constipation in patients with cancer. Support Care Cancer. 2020;28:1793–7.
5. DiCello JJ, Carbone SE, Saito A, Rajasekhar P, Ceredig RA, Pham V, et al. Mu and Delta Opioid Receptors Are Coexpressed and functionally interact in the enteric nervous system of the mouse Colon. Cell Mol Gastroenterol Hepatol. 2020;9:465–83.